Vistin Pharma ASA (VISTN) — Capital Reinvestment Ratio
Vistin Pharma ASA (VISTN) has a Capital Reinvestment Ratio of 0.54x as of June 2025, meaning it reinvests 1% of its operating cash flow (Nkr6.37 Million) in capital expenditures (Nkr3.43 Million). See VISTN equity to assets ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Vistin Pharma ASA Capital Reinvestment Ratio (2016–2024)
This chart tracks Vistin Pharma ASA's Capital Reinvestment Ratio across 6 annual periods. Check Vistin Pharma ASA investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Vistin Pharma ASA (2016–2024)
Year-by-year Capital Reinvestment Ratio for Vistin Pharma ASA from 2016 to 2024. For live market cap and broader valuation context, see VISTN market cap.
| Year | Reinvestment Ratio | Operating CF (NOK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.38x | Nkr107.86 Million | Nkr40.80 Million | ▲ +91.5% |
| 2023 | 0.20x | Nkr90.59 Million | Nkr17.90 Million | ▼ -91.5% |
| 2021 | 2.33x | Nkr13.68 Million | Nkr31.94 Million | ▲ +140.8% |
| 2019 | 0.97x | Nkr18.93 Million | Nkr18.36 Million | ▼ -74.1% |
| 2017 | 3.74x | Nkr9.51 Million | Nkr35.55 Million | ▲ +1136.9% |
| 2016 | 0.30x | Nkr53.84 Million | Nkr16.27 Million | — |